期刊文献+

血清糖化血红蛋白和糖类抗原15-3表达水平与乳腺癌发病风险的相关性 被引量:1

下载PDF
导出
摘要 目的探讨血清糖化血红蛋白(GHb)、糖类抗原15-3(CA15-3)表达水平与乳腺癌发病风险的相关性。方法选取2015年6月至2017年8月医院收治的86例乳腺癌患者(均为女性)作为试验组,选取同期收治的86例乳腺良性肿瘤患者(均为女性)作为对照组,比较两组血清GHb、CA15-3水平,并分析血清GHb、CA15-3表达水平与女性乳腺癌发病风险的相关性。结果试验组血清GHb、CA15-3水平均高于对照组,差异有统计学意义(P<0.05)。将是否患乳腺癌作为因变量(1=是,0=不是),GHb、CA15-3作为协变量,经Logistic回归分析结果显示,血清GHb、CA15-3水平高表达可能与女性乳腺癌发病有关(OR>1,P<0.05)。结论血清GHb、CA15-3水平高表达与女性乳腺癌发病相关,应加强预防措施,控制血清GHb、CA15-3水平,以降低发病率。
作者 张涵
出处 《医疗装备》 2021年第11期50-51,共2页 Medical Equipment
  • 相关文献

二级参考文献75

  • 1Sturgeon CM,Duffy MJ,Stenman UH,et al.National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular,prostate,colorectal,breast,and ovarian cancers[J].Clin Chem,2008,54(12):e11-e79. 被引量:1
  • 2Shaw JA,Stebbing J.Circulating free DNA in the management of breast cancer[J].Ann Transl Med,2014,2(1):3. 被引量:1
  • 3Duffy MJ,Evoy D,McDermott EW.CA15-3:uses and limitation as a biomarker for breast cancer[J].Clin Chim Acta,2010,411(23-24):1869-1874. 被引量:1
  • 4Khatcheressian JL,Hurley P,Bantug E,et al.Breast cancer follow-up and management after primary treatment:American Society of Clinical Oncology clinical practice guideline update[J].J Clin Oncol,2013,31(7):961-965. 被引量:1
  • 5Molina R,Barak V,van Dalen A,et al.Tumor markers in breast cancer-European Group on Tumor Markers recommendations[J].Tumour Biol,2005,26(6):281-293. 被引量:1
  • 6Senkus E,Kyriakides S,Ohno S,et al.Primary breast cancer:ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up[J].Ann Oncol,2015,26(Suppl 5):v8-v30. 被引量:1
  • 7Sliwowska I,Kopczyński Z,Grodecka-Gazdecka S.Diagnostic value of measuring serum CA15-3,TPA,and TPS in women with breast cancer[J].Postepy Hig Med Dosw(Online),2006,60:295-299. 被引量:1
  • 8Atoum M,Nimer N,Abdeldayem S,et al.Relationships among serum CA15-3 tumor marker,TNM staging,and estrogen and progesterone receptor expression in benign and malignant breast lesions[J].Asian Pac J Cancer Prev,2012,13(3):857-860. 被引量:1
  • 9O′Hanlon DM,Kerin MJ,Kent P,et al.An evaluation of preoperative CA15-3 measurement in primary breast carcinoma[J].Br J Cancer,1995,71(6):1288-1291. 被引量:1
  • 10Molina R,AugéJM,Escudero JM,et al.Evaluation of tumor markers(HER-2/neu oncoprotein,CEA,and CA15.3)in patients with locoregional breast cancer:prognostic value[J].Tumour Biol,2010,31(3):171-180. 被引量:1

共引文献52

同被引文献21

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部